Predictions
Catalent Inc.
Start price
Target price
Perf. (%)
€42.50
15.04.23
15.04.23
-
15.04.24
15.04.24
-22.00%
19.05.23
19.05.23
Could be worthwhile Investment >10% per year
Catalent Inc.
Start price
Target price
Perf. (%)
€42.50
15.04.23
15.04.23
€20.00
15.04.24
15.04.24
8.59%
29.04.23
29.04.23
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
Risky balance sheet
ViewRay Inc
Start price
Target price
Perf. (%)
€1.20
15.04.23
15.04.23
€1.00
15.04.24
15.04.24
-11.67%
29.04.23
29.04.23
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Dependend from some customers or products
high free float
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.28
15.04.23
15.04.23
€2.00
15.04.24
15.04.24
12.98%
29.04.23
29.04.23
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.20
14.04.23
14.04.23
-
14.04.24
14.04.24
-0.07%
16.04.23
16.04.23
Axonics Modulation Technologies Inc
Start price
Target price
Perf. (%)
€50.50
13.04.23
13.04.23
-
13.04.24
13.04.24
23.76%
14.04.24
14.04.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€33.50
13.04.23
13.04.23
€59.72
13.04.24
13.04.24
-29.85%
14.04.24
14.04.24
Merit Medical Systems
Start price
Target price
Perf. (%)
€69.50
13.04.23
13.04.23
€70.58
13.04.24
13.04.24
-3.60%
14.04.24
14.04.24
Pulse Biosciences Inc
Start price
Target price
Perf. (%)
€4.58
13.04.23
13.04.23
-
13.04.26
13.04.26
-14.85%
26.09.23
26.09.23
Risky Investment
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.30
12.04.23
12.04.23
€30.00
12.04.24
12.04.24
-0.59%
17.04.23
17.04.23
Could be very worthwhile Investment >20% year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.80
11.04.23
11.04.23
€119.08
11.04.24
11.04.24
13.29%
12.04.24
12.04.24